Search clinical trials for: BCT194

Total 11 results

Novartis

Completed

Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.

Psoriasis

Austria
Novartis Pharmaceuticals

Completed

Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients

Psoriasis

Austria
Mereo BioPharma
Novartis

Terminated

Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery

Acute Kidney Injury

Taiwan, United States, Israel
Mereo BioPharma

Completed

Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

United States, Bulgaria, Czechia, Germany, Hungary, Italy, Latvia, Poland, Romania, Russian Federation
Mereo BioPharma
Novartis

Completed

Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an Exacerbation

Chronic Obstructive Pulmonary Disease

Russian Federation, Bulgaria, Romania
Biocity Biopharmaceutics Co., Ltd.

Recruiting

Study of BC3195 Monotherapy in Patients With Advanced Solid Tumors (BC3195)

Locally Advanced or Metastatic Solid Tumors

China
Novo Nordisk A/S

Completed

A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese Men

Non-alcoholic Fatty Liver Disease

China
Mereo BioPharma

Completed

The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers

Interaction

United Kingdom
Cipla BioTec Pvt. Ltd.
Quintiles, Inc.

Unknown

PK Bioequivalence Single-dose Safety Tolerability Study in Healthy Male Volunteers to Compare CBT124 & Avastin(EU&US) (CBT124NHV001)

Healthy

New Zealand
Mereo BioPharma

Completed

The Effect of Itraconazole on BCT197 Exposure in Healthy Male Participants

Interaction

United States
Cipla BioTec Pvt. Ltd.

Unknown

Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC

Non-Small Cell Lung Carcinoma

3

Subscribe